Plus more of the stocks making headlines in U.S. markets Tuesday
From Standard & Poor's Equity ResearchApple Inc (AAPL)
ThinkEquity downgrades to accumulate from buy.
Amer Commercial (ACLI)
Cuts $1.75-$1.95 2007 EPS guidance to $1.45-$1.65, vs. Street's $1.84 est... Cites further weakness in spot grain markets, lower-than-planned productivity levels in mfg segment... Morgan Keegan cuts ests.
Geron Corp (GERN)
Announces its telomerase inhibitor cancer drug, GRN163L, has demonstrated good pharmacokinetics, tolerability in its ongoing Ph. I/II trial involving patients with chronic Lymphocytic leukemia.
Ecolab Inc (ECL)
Credit Suisse upgrades to outperform from neutral... the company unavailable.
Diodes, Inc (DIOD)
Expects 3%-5% second quarter sequential revenue growth, vs. previously projected 2%-5% second quarter sequential revenue growth.
Grainger (w.w.) (GWW)
Posted 8% higher May daily sales... The company says sales growth was partially offset by decline in sales under certain low-margin contracts with integrated supply customers.
Par Pharmaceutic (PRX)
Gets exclusive license from IMMTECH PHARMACEUTICALS to commercialize IMM's lead oral drug, pafuramidine maleate, in US for treatment of pneumocystis pneumonia (PCP) in AIDS patients.
Cyberonics Inc (CYBX)
Posted 42 cents Q4 loss vs. 17 cents loss on 13% sales decline... Expects fiscal 08 operating results to improve.
Inter-tel Inc (INTL)
Special committee of its board tells co.'s stockholders that recapitalization strategy proposed by Steven G. Mihaylo not reasonably likely to lead to more favorable transaction than merger with Mitel Networks Corp.
Cal Dive Intl (DVR)
Offers to acquire HORIZON OFFSHORE in cash, stock deal valued at about $650M, including approximately $22M of debt.
Indevus Pharmace (IDEV)
The company says progress from its Phase II EXPRESS trial for pagoclone in persistent developmental stuttering has been extremely encouraging.
Jos. A. Bank Clot (JOSB)
First Albany upgrades to neutral from sell... Yesterday co. Posted 45 cents vs. 32 cents first quarter EPS on 3.8% higher same-store sales, 14% higher total sales.
Chicago Merc Exc (CME)
Co., CBOT HOLDINGS INC. receive clearance from US Dept of Justice to complete their proposed merger without conditions.
Aspect Medical Systems (ASPM)
To acquire 2M of its shares held by BOSTON SCIENTIFIC for about $15.91 per sh.; ASPM has right to buy any or all of BSX's remaining ASPM shs... Cos. end alliance... Ups second quarter view 5 cents-$0.07 GAAP EPS on $26.1M-$27.1M rev.
Stewart Enterpri (STEI)
Posted 13 cents vs. 11 cents second quarter EPS from cont. ops on 5.3% higher total revenue.
Lehman Br Holdin (LEH)
Posted $2.21 vs. $1.69 second quarter EPS on 9.2% higher net revenue.
Horizon Offshore (HOFF)
CAL DIVE INTL offers to acquire HOFF in cash, stock deal valued at about $650M, including approximately $22M of debt.
Texas Instrument (TXN)
Sees 40 cents-$0.44 second quarter EPS from cont. ops on revenue of $3.36B-$3.51B, vs. previous guidance of 39 cents-$0.45 EPS on revenue of $3.32B-$3.60B... S&P reiterates buy... See Pg. 4
Take-two Interac (TTWO)
Posted 71 cents second quarter GAAP loss vs. 71 cents loss on 23% sales decline... Posted 41 cents non-GAAP loss... Sets restructure plan; will incl. layoffs... Sees third quarter rev. of $195M-$215M, 60 cents-$0.65 GAAP loss; sees Q4 EPS of $1.35-$1.40.
Dean Foods (DF)
Notes milk prices have risen rapidly, its Horizon Organic brand facing significant industry-wide oversupply of raw organic milk... Cuts EPS forecasts to 30 cents-$0.31 for second quarter, 2007 adj. EPS to $1.52-$1.58.
Koor Indus Ltd A (KOR)
Says has discontinued negotiations for sale of its entire 61% stake Telrad Networks Ltd.
Coley Pharmaceut (COLY)
Agrees to acquire majority of 3M CO.'s therapeutic Toll-like receptor cancer programs... MMM will receive cash payments totaling $20M over 3-year period, possible milestone payments, royalties from sale of any products.
Curagen Corp (CRGN)
Presents updated results from clinical development program suggesting clinical activity of its belinostat drug against cutaneous T-cell lymphoma (CTCL), peripheral T-cell lymphoma (PTCL), ovarian cancers.
Vical Inc (VICL)
Wins 3-year, $6M grant from National Institute of Allergy and Infectious Diseases for further development of DNA vaccine mfg process with potential to produce several million doses of vaccines in matter of days.
Luby's Inc (LUB)
Posts $0.14 vs. $0.25 Q3 EPS 1.9% lower same-store sales, 2.7% lower total sales... Expects Q4 sales trends to be similar to Q2, Q3.
Idenix Pharmaceu (IDIX)
Says results from phase II study of its valopicitabine combined with standard of care achieved both primary, secondary endpoints of study; no negative drug-drug interaction observed between it, ribavirin.
Source Interlink (SORC)
Posts $0.06 vs. $0.05 Q1 GAAP EPS from cont. ops on 6.1% revenue rise.
Amer Capital Strategies (ACAS)
Plans to publicly offer 17M shares.